Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease

Neurobiology of Aging

Volumn 38, Issue , 2015, Pages 217.e7-217.e8

  Zhang, Ming ^a   Xi, Zhengrui ^a   Fang, Shilun ^a   Ghani, Mahdi ^a   Sato, Christine ^a   Moreno, Danielle ^a   Liang, Yan ^a   Lang, Anthony E ^b,c   Rogaeva, Ekaterina ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canadian; CHCHD2; Mutation; Parkinson's disease

Indexed keywords

ISOLEUCINE; LEUCINE; METHIONINE; PROLINE; SERINE; CHCHD2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANADIAN; CHCHD2 GENE; EXON; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENE; MUTATIONAL ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; CANADA; DNA MUTATIONAL ANALYSIS; GENETIC ASSOCIATION STUDY; GENETICS; MUTATION;

CANADA; DNA MUTATIONAL ANALYSIS; EXONS; GENETIC ASSOCIATION STUDIES; HUMANS; MITOCHONDRIAL PROTEINS; MUTATION; PARKINSON DISEASE; TRANSCRIPTION FACTORS;

EID: 85017075140     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.10.038     Document Type: Article

References (10)

1. Ajroud-Driss S., Fecto F., Ajroud K., Lalani I., Calvo S.E., Mootha V.K., Deng H.X., Siddique N., Tahmoush A.J., Heiman-Patterson T.D., Siddique T. Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy. Neurogenetics 2015, 16:1-9.
2. Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G., Verschueren A., Rouzier C., Le Ber I., Auge G., Cochaud C., Lespinasse F., N'Guyen K., de Septenville A., Brice A., Yu-Wai-Man P., Sesaki H., Pouget J., Paquis-Flucklinger V. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 2014, 137(Pt 8):2329-2345.
3. Foo J.N., Liu J., Tan E.K. CHCHD2 and Parkinson's disease. Lancet Neurol. 2015, 14:681-682.
4. Funayama M., Ohe K., Amo T., Furuya N., Yamaguchi J., Saiki S., Li Y., Ogaki K., Ando M., Yoshino H., Tomiyama H., Nishioka K., Hasegawa K., Saiki H., Satake W., Mogushi K., Sasaki R., Kokubo Y., Kuzuhara S., Toda T., Mizuno Y., Uchiyama Y., Ohno K., Hattori N. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015, 14:274-282.
5. Ghani M., Lang A.E., Zinman L., Nacmias B., Sorbi S., Bessi V., Tedde A., Tartaglia M.C., Surace E.I., Sato C., Moreno D., Xi Z., Hung R., Nalls M.A., Singleton A., St George-Hyslop P., Rogaeva E. Mutation analysis of patients with neurodegenerative disorders using NeuroX array. Neurobiol. Aging 2015, 36:545.e9-545.e14.
6. Hughes A.J., Daniel S.E., Lees A.J. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001, 57:1497-1499.
7. Jansen I.E., Bras J.M., Lesage S., Schulte C., Gibbs J.R., Nalls M.A., Brice A., Wood N.W., Morris H., Hardy J.A., Singleton A.B., Gasser T., Heutink P., Sharma M. CHCHD2 and Parkinson's disease. Lancet Neurol. 2015, 14:678-679. IPDGC.
8. Liu G., Li K. CHCHD2 and Parkinson's disease. Lancet Neurol. 2015, 14:679-680.
9. Liu Z., Guo J., Li K., Qin L., Kang J., Shu L., Zhang Y., Wei Y., Yang N., Luo Y., Sun Q., Xu Q., Yan X., Tang B. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease. Neurobiol. Aging 2015, 36:3117.e7-3117.e8.
10. Zhang M., Xi Z., Zinman L., Bruni A.C., Maletta R.G., Curcio S.A., Rainero I., Rubino E., Pinessi L., Nacmias B., Sorbi S., Galimberti D., Lang A.E., Fox S., Surace E.I., Ghani M., Guo J., Sato C., Moreno D., Liang Y., Keith J., Traynor B.J., St George-Hyslop P., Rogaeva E. Mutation analysis of CHCHD10 in different neurodegenerative diseases. Brain 2015, 138(Pt 9):e380.